2026 NPPES data Sports Medicine (Neuromusculoskeletal Medicine) Physician NPI 1497718688 M.D.
Verify on CMS →

JOHN ANIGBOGU, M.D.

Sports Medicine (Neuromusculoskeletal Medicine) Physician in HOUSTON, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
525
Medicare Part D claims · 87 beneficiaries · Sports Medicine (Neuromusculoskeletal Medicine) Physician avg: 1K
Generic prescribing
93%
generic claims · 7% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
0/100
▼ 83 pts below national avg 83.1 · [object Object]

What the federal data shows

JOHN ANIGBOGU, M.D. reported a CMS MIPS final score of 0/100 — below the 83.1 national average — and filed 525 Medicare Part D claims in 2023.

0/100
MIPS score · -83 vs avg
525
Part D claims, 2023
93%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

JOHN ANIGBOGU, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

0 0th percentile higher than 0% of 477,587 scored providers

0–10: 8,684 scored providers (2%). This entry sits in this band. 10–20: 3,008 scored providers (1%). Above this entry. 20–30: 3,069 scored providers (1%). Above this entry. 30–40: 2,746 scored providers (1%). Above this entry. 40–50: 2,928 scored providers (1%). Above this entry. 50–60: 5,882 scored providers (1%). Above this entry. 60–70: 13,906 scored providers (3%). Above this entry. 70–80: 118,074 scored providers (25%). Above this entry. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

JOHN ANIGBOGU, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about JOHN ANIGBOGU, M.D.?

Below national average

NPI registry status

Active

Issued 04/10/2006

NPI 1497718688

Primary specialty

Sports Medicine (Neuromusculoskeletal Medicine) Physician

Niche

552 US NPIs in this specialty

Medicare Part D claims

525 53% vs specialty avg

2023 prescription claims

Specialty avg: 1,113

MIPS final score

0/100 83.1% pts

Penalty band band

vs 83.1 national avg

Specialty distribution in Texas

How Sports Medicine (Neuromusculoskeletal Medicine) Physician compares to other specialties among Texas providers

Texas providers

Sports Medicine (Neuromusculoskeletal Medicine) Physician share within Texas

1. Sports Medicine (Neuromusculoskeletal Medicine) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Sports Medicine (Neuromusculoskeletal Medicine) Physician share within Texas

Medicare quality performance — MIPS

JOHN ANIGBOGU, M.D.'s 2023 MIPS final score plotted against the Sports Medicine (Neuromusculoskeletal Medicine) Physician national average

Below national average
MIPS Final Score
0/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Sports Medicine (Neuromusculoskeletal Medicine) Physician) — 0/100 vs national avg 83.1

0%100%National avg83%0%
MIPS final score (Sports Medicine (Neuromusculoskeletal Medicine) Physician) — 0/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

JOHN ANIGBOGU, M.D. is a Sports Medicine (Neuromusculoskeletal Medicine) Physician provider practicing in HOUSTON, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1497718688. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

JOHN ANIGBOGU, M.D. appears in the CMS NPPES registry as a Sports Medicine (Neuromusculoskeletal Medicine) Physician provider holding M.D. credentials at 11000 FONDREN RD, HOUSTON, TX, 77096, with a listed phone of (713) 271-2800. NPI 1497718688 was issued on 04/10/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what ANIGBOGU most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 525 prescription claims written by this provider, covering 87 Medicare beneficiaries and totaling roughly $64K in drug spend, split 7% brand-name and 93% generic by claim count, with an opioid prescribing rate of 49.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 0/100 for the 2023 performance year (Quality 0), compared with the national average of 83.1.

Sports Medicine (Neuromusculoskeletal Medicine) Physician is a narrow specialty nationwide, with 552 enrolled providers across 51 states and an average of 1,113 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

11000 FONDREN RD
HOUSTON, TX 77096

Provider Details

NPI 1497718688
Specialty Sports Medicine (Neuromusculoskeletal Medicine) Physician
Credentials M.D.
Gender Male
NPI Issued 04/10/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

0
Final Score
Avg: 83.1
0
Quality

Reporting: Individual

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to JOHN ANIGBOGU, M.D.. To verify JOHN ANIGBOGU, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

JOHN ANIGBOGU, M.D. — brand share 7.0%
Specialty average (est.)

7% brand-name claims vs 93% generic, on 525 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

525
Total Claims
$64K
Total Drug Cost
87
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
664
Total Day Supply
18,176
Brand vs Generic
7% brand / 93% generic
Brand Drug Cost
$25K
Generic Drug Cost
$39K
Opioid Claims
258 (49.1% rate)

Patient Demographics

Average Patient Age
68.9 years
Avg HCC Risk Score
2.41
Gender Split
61% female / 39% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Oxycodone Hcl
93
Hydrocodone-Acetaminophen
Hydrocodone/Acetaminophen
77
Pregabalin
37
Tramadol Hcl
28
Gabapentin
25
Morphine Sulfate Er
Morphine Sulfate
25
Tizanidine Hcl
14
Diclofenac Sodium
12
Hydromorphone Hcl
12
Oxycontin
Oxycodone Hcl
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Sports Medicine (Neuromusculoskeletal Medicine) Physician Overview

How JOHN ANIGBOGU, M.D. fits within the Sports Medicine (Neuromusculoskeletal Medicine) Physician landscape nationally.

552
Sports Medicine (Neuromusculoskeletal Medicine) Physician Providers in US
51
States with Sports Medicine (Neuromusculoskeletal Medicine) Physician
1,113
Avg Claims per Provider

JOHN ANIGBOGU, M.D.'s 525 claims are below the specialty average of 1,113.

Nearby Sports Medicine (Neuromusculoskeletal Medicine) Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as ANIGBOGU.

Compare Sports Medicine (Neuromusculoskeletal Medicine) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is JOHN ANIGBOGU, M.D.'s specialty?
JOHN ANIGBOGU, M.D. specializes in Sports Medicine (Neuromusculoskeletal Medicine) Physician and practices in HOUSTON, Texas. Credentials: M.D..
How much does JOHN ANIGBOGU, M.D. prescribe under Medicare Part D?
In 2023, JOHN ANIGBOGU, M.D. wrote 525 Medicare Part D claims totaling $64K in drug costs for 87 beneficiaries.
What is JOHN ANIGBOGU, M.D.'s Medicare quality score?
JOHN ANIGBOGU, M.D. has a CMS MIPS Final Score of 0/100 (Quality: 0). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is JOHN ANIGBOGU, M.D. located?
JOHN ANIGBOGU, M.D. is located at 11000 FONDREN RD, HOUSTON, TX, 77096. Phone: (713) 271-2800.
What is JOHN ANIGBOGU, M.D.'s NPI number?
JOHN ANIGBOGU, M.D.'s National Provider Identifier (NPI) is 1497718688, issued on 04/10/2006.
Does JOHN ANIGBOGU, M.D. prescribe more brand-name or generic drugs?
JOHN ANIGBOGU, M.D.'s prescribing is 7% brand-name and 93% generic drugs by claim count, with $25K in brand drug costs.
Does JOHN ANIGBOGU, M.D. prescribe opioids?
Yes, JOHN ANIGBOGU, M.D. had 258 opioid claims in 2023 with an opioid prescribing rate of 49.1%.
How many Sports Medicine (Neuromusculoskeletal Medicine) Physician providers are there in the US?
There are 552 Sports Medicine (Neuromusculoskeletal Medicine) Physician providers across 51 states in the US. The average Sports Medicine (Neuromusculoskeletal Medicine) Physician provider writes 1,113 Medicare Part D claims per year.
What drugs does JOHN ANIGBOGU, M.D. prescribe most often?
Based on 2023 Medicare Part D data, JOHN ANIGBOGU, M.D.'s most frequently prescribed drugs include Oxycodone Hcl, Hydrocodone-Acetaminophen, Pregabalin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does JOHN ANIGBOGU, M.D. accept Medicare?
JOHN ANIGBOGU, M.D. appears in CMS Medicare data with 525 Part D claims and 87 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify JOHN ANIGBOGU, M.D.'s credentials?
JOHN ANIGBOGU, M.D.'s NPI is 1497718688 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology